BALOXAVIR MARBOXIL (Xofluza®)

Clinical Indication

Treatment and post exposure prophylaxis of influenza as per UKHSA guidelines

Comments

For Influenza as per UKHSA guidelines.

On virology advice only

Date of classification

February 2026

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.